Celebrating the Vision and Leadership of Professor Dzifa Dey

tRi Ghana • March 5, 2026

On March 5th, we celebrate the birthday of Ida Dzifa Dey, Founder and Director of The Rheumatology Initiative (tRi) Ghana; a visionary physician whose work has significantly shaped the field of rheumatology in Ghana and across Africa.


Professor Dey’s dedication to improving care for people living with autoimmune diseases has transformed the landscape of rheumatology in the country and inspired many healthcare professionals to pursue this important specialty.


A Pioneer in Rheumatology

Dzifa Dey is a Consultant Physician and Rheumatologist at the Korle Bu Teaching Hospital and a Professor at the University of Ghana Medical School.


Her pioneering work includes establishing Ghana’s first rheumatology clinic at Korle Bu Teaching Hospital in 2009, a milestone that opened the door for improved diagnosis and treatment of autoimmune and musculoskeletal diseases in the country.


Recognising the urgent need for awareness, education, and patient support, she founded The Rheumatology Initiative (tRi) Ghana in 2012. The organisation focuses on raising awareness, supporting patients, and promoting research into autoimmune rheumatic diseases across Ghana and the wider African region.


A Passion for Advocacy and Education

Throughout her career, Professor Dey has worked tirelessly to address the lack of awareness surrounding autoimmune diseases. These conditions are often misunderstood, leading many patients to suffer silently or receive delayed diagnoses.


Through her leadership, numerous awareness campaigns, educational programmes, and patient support initiatives have been launched to help bridge this knowledge gap. The organisation also creates platforms where patients and families can learn about their conditions, connect with others, and access valuable health information.


Her work has also contributed to the training and mentoring of many medical professionals in the field of rheumatology, strengthening healthcare capacity across the region.


International Recognition

Professor Dey’s contributions to global rheumatology have been widely recognised. She has received several honours, including the Distinguished International Rheumatology Professional Award from the American College of Rheumatology for her advocacy and public health contributions to the global rheumatology community.


Her research interests include autoimmune diseases such as systemic lupus erythematosus and other connective tissue disorders, with a focus on improving patient outcomes in resource-limited settings.


A Legacy of Hope

Beyond her professional achievements, Professor Dey is widely respected for her compassion and dedication to patients living with chronic illness. She has consistently championed the belief that individuals living with autoimmune diseases deserve dignity, understanding, and access to quality healthcare.


Her leadership continues to inspire a growing movement focused on improving rheumatology care across Africa.


Celebrating a Life of Impact

As we celebrate Professor Dzifa Dey’s birthday, we recognise not only her remarkable achievements but also her unwavering commitment to transforming lives through medicine, research, and advocacy.


Her work continues to bring hope to patients, families, and healthcare professionals working toward a future where autoimmune diseases are better understood, diagnosed earlier, and managed more effectively.


Happy Birthday, Professor Dey, and thank you for your continued dedication to improving lives.

By tRi Ghana June 4, 2026
Learn why early diagnosis and treatment are critical for improving outcomes in people living with rheumatic and musculoskeletal diseases. tRi Ghana
By tRi Ghana May 11, 2026
Read the latest tRi2Day Newsletter – 1st Quarter 2026 Edition featuring rheumatology updates, awareness activities, patient advocacy initiatives, and events.
By tRi Ghana April 17, 2026
Learn why raising awareness of rheumatic diseases in Ghana is critical and how early care improves outcomes by preventing permanent disability and joint damage.
More Posts